We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

APEX:ADXAPEX INVESTMENT P.S.C Analysis

Data as of 2026-06-13 - not real-time

₹48.46

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical outlook: the stock trades at 48.46, just below its 20‑day SMA of 48.47 and well under the 50‑day SMA of 50.05, while the 200‑day SMA sits at 82.90, indicating a strong bearish bias. Momentum is neutral with an RSI of 45.6 and a MACD histogram that turned positive, giving a brief bullish signal, but the overall trend remains bearish. The price is hovering near the identified support at 46.61 and faces resistance around 52.98, with volume trending downward and a 30‑day volatility of 36.5%, suggesting fragile price stability. Fundamental health: revenue has risen over 140% year‑on‑year, yet operating margin is –44% and profit margin –144%, resulting in a trailing EPS of –4.87 and zero EBITDA. The company carries no debt and holds INR 31.27 M of cash, but operating cash flow is negative (‑15.76 M), and free cash flow remains zero. Valuation metrics are mixed: a very low price‑to‑book of 0.15 points to potential undervaluation, while a price‑to‑sales of 28.8 and negative earnings signal significant value concerns. Risk profile: beta of 0.59 denotes modest market sensitivity, yet a historic max drawdown of –60.5% and high 30‑day volatility amplify downside risk, compounded by low liquidity (average volume ~8 k shares).

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below key moving averages and near support
  • Negative earnings and cash flow
  • High volatility and decreasing volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Zero debt and cash cushion
  • Persistent operating losses
  • Potential for restructuring but uncertain outlook

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Very low price‑to‑book suggests cheap entry
  • Lack of profitability and high drawdown risk
  • Sector exposure to credit cycles and regulatory changes

Key Metrics & Analysis

Financial Health

Revenue Growth143.80%
Profit Margin-144.85%
ROE-1.49%
ROA-1.27%
P/B Ratio0.1
Op. Cash Flow₹-15762000
Industry P/E16.8

Technical Analysis

TrendBearish
RSI45.6
Support₹46.61
Resistance₹52.98
MA 20₹48.47
MA 50₹50.05
MA 200₹82.90
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.59
Volatility36.52%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.